ClinicalTrialsFinder

Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) Clinical Trials in Shenyang, Liaoning

1 recruitingShenyang, Liaoning, China

Showing 1–1 of 1 trials

Recruiting
Phase 3

Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)

Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
Jiangsu vcare pharmaceutical technology co., LTD1,000 enrolled1 locationNCT06577519